Definiens is a leading biotechnology company based in Encinitas, CA, dedicated to transforming the future of healthcare through the power of science. With a focus on precision medicine and data science, they are committed to developing innovative therapies and technologies in areas such as oncology, cardiovascular health, respiratory diseases, and rare diseases.
Driven by a strong research approach and a dedication to inclusivity and diversity, Definiens aims to improve patient outcomes by accurately classifying diseases, identifying new biomarkers, and targeting specific molecular causes. With a global presence and a robust pipeline of projects, they are at the forefront of scientific advancements in healthcare.
Generated from the website